FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.onkologie |
| Resource Type | CarePlan |
| Id | CarePlan-mii-exa-onko-tumorkonferenz-molekular.json |
| FHIR Version | R4 |
No resources found
No resources found
No narrative content found in resource
{
"resourceType": "CarePlan",
"id": "mii-exa-onko-tumorkonferenz-molekular",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-tumorkonferenz|2026.0.1"
]
},
"status": "active",
"intent": "plan",
"category": [
{
"coding": [
{
"system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapieplanung-typ",
"code": "praeth"
}
],
"text": "Molekulares Tumorboard"
}
],
"subject": {
"reference": "Patient/example"
},
"created": "2024-01-15",
"addresses": [
{
"reference": "Condition/primaertumor-example"
}
],
"activity": [
{
"detail": {
"code": {
"coding": [
{
"system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
"code": "ZS"
}
],
"text": "Zielgerichtete Anti-HER2 Therapie"
},
"status": "not-started",
"description": "Basierend auf HER2-Amplifikation: Trastuzumab + Pertuzumab Kombination empfohlen"
}
},
{
"detail": {
"code": {
"coding": [
{
"system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
"code": "CZ"
}
],
"text": "Chemotherapie + CDK4/6 Inhibitor"
},
"status": "not-started",
"description": "Alternative basierend auf HR+/HER2- Status: Palbociclib + Letrozol"
}
},
{
"detail": {
"code": {
"coding": [
{
"system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
"code": "ST"
}
],
"text": "Strahlentherapie"
},
"status": "not-started",
"description": "Adjuvante Bestrahlung nach Operation"
}
}
]
}